Author

O. Eriksson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

C. B. Jackson· 1 shared H. Ali-Loytty· 1 shared H. Cabral· 1 shared H. Tsang· 1 shared H. Zhao· 1 shared J. Antunes· 1 shared J. Hellgren Kotaleski· 1 shared J. Hilborn· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

C. B. Jackson

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

GTPBP8 is required for mitoribosomal biogenesis and mitochondrial translation

L. Wang, T. Hilander, X. Liu, H. Tsang, O. Eriksson, C. B. Jackson, M. Varjosalo, H. Zhao

This study identifies GTPBP8 as a critical factor for mitoribosomal assembly and mitochondrial translation, showing its depletion impairs subunit maturation and function.

bioRxiv · May 26, 2023Cell Biology

Heparin-derived theranostic nanoprobes overcome the blood-brain barrier and target glioma in murine model

S. Samanta, V. Le Joncour, O. Wegrzyniak, V. Rangasami, H. Ali-Loytty, T. Hong, R. K. Selvaraju, O. Aberg, J. Hilborn, P. Laakkonen, O. P. Varghese, O. Eriksson, H. Cabral, O. P. Oommen

This study develops heparin-derived nanoprobes that cross the blood-brain barrier and target glioma in mice, showing effective imaging and therapeutic potential.

bioRxiv · Jan 7, 2022Bioengineering

AKAP79 enables calcineurin to directly suppress protein kinase A activity

T. W. Church, P. Tewatia, S. Hannan, J. Antunes, O. Eriksson, T. G. Smart, J. Hellgren Kotaleski, M. Gold

This study shows AKAP79 enhances calcineurin's ability to suppress PKA activity by increasing dephosphorylation rates of PKA regulatory subunits, contributing to synaptic LTD.

bioRxiv · Mar 14, 2021Biochemistry